Company / SG&A per Share
Moleculin Biotech, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$65.01
FY2025
5-year range
$0.59 / $65.01
FY2021-FY2025
Trend
+1345.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +1346% YoY in FY2025, a notable deviation from the 8-year average annual change of +342%.
Based on SEC 10-K filings.
65.01 in FY2025 with a 5-year CAGR of +139.3%.
Increased from $6.05 to $65.01 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +139.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 1345.6% year-over-year.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $65.01 | +1345.6% |
| FY2024 | $4.50 | -25.6% |
| FY2023 | $6.05 | - |
| FY2022 | - | - |
| FY2021 | $0.59 | -29.0% |
| FY2020 | $0.83 | +351.9% |
| FY2019 | $0.18 | -3.8% |
| FY2018 | $0.19 | -2.7% |
| FY2017 | $0.20 | +172.9% |
| FY2016 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026